15th week of 2013 patent applcation highlights part 38 |
Patent application number | Title | Published |
20130090426 | PHTHALATE-FREE ISOCYANURATE FORMULATIONS - The present invention relates to novel low-monomer-content, low-viscosity, high-activity preparations made of isocyanurates containing isocyanate groups and of phthalate-free plasticizers, to use of the same as adhesion promoters with improved adhesion for coating compositions based on plasticized polyvinyl chloride, and also to coatings and coated substrates. | 2013-04-11 |
20130090427 | END-MODIFIED DIENE COPOLYMER HAVING GOOD COMPATIBILITY WITH REINFORCING SILICA AND PREPARATION METHOD THEREOF - The present invention provides an end-modified diene copolymer having excellent compatibility with silica as a reinforcement material, and a preparation process thereof, in which the end-modified diene copolymer is prepared by preparing a living polymer of a conjugated diene monomer and/or a vinyl aromatic monomer, modifying the living polymer with a reactive organosiloxane compound, and then modifying the end of the living polymer, to which the organosiloxane compound has not been coupled, with an organosilane compound having various functional groups. When the end-modified diene copolymer is used as a rubber material in the manufacture of a silica tire, the dispersion of silica in the copolymer can be improved and the bonding strength between silica and the rubber can be significantly increased, thereby manufacturing a high-quality silica tire. | 2013-04-11 |
20130090428 | COATING AGENT FOR HAND PAINTING APPLICATION - A coating agent for hand painting application obtained by a urethane resin composition obtained by allowing a main agent (A) and a curing agent (B) to react. The main agent (A) containing: an isocyanate group-terminated prepolymer (b) having diphenylmethane diisocyanate bound to the termini of a polyol component (a) containing a long chain polyol (e) which contains at least a polyhydroxy functional product such as a trihydroxy or higher-hydroxy functional product and having a molecular weight of 200 or greater; and unbound diphenylmethane diisocyanate(c). The curing agent (B) containing: a crosslinking agent (g) obtained by a short chain polyol (f) having a molecular weight of less than 200; and a long chain polyol (h) having a molecular weight of 200 or greater. | 2013-04-11 |
20130090429 | LOW VISCOSITY SILYL-TERMINATED POLYMERS - Embodiment of the invention provide for compositions having at least one crosslinkable silyl group in each molecule. The crosslinkable silane-terminated polymer may include a reaction product of at least a polyol having a nominal functionality of at least 2 and a isocyanate capped hydrosilylated polymer. The isocyanate capped hydrosilylated polymer may include a reaction product of at least one isocyanate and a hydrosilylated polymer. The hydrosilylated polymer may include a reaction product of a the reaction of at least a) a polymer having at least one unsaturated group and at least one alcoholic hydroxyl group in each molecule and having a number average molecular weight of between about 100 and about 5000 and b) a compound having a hydrogen-silicon bond and a crosslinkable silyl group in each molecule. | 2013-04-11 |
20130090430 | PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT POLYETHYLENE - In a process for producing polyethylene having a molecular weight of at least 3×105 g/mol as determined by ASTM 4020, ethylene is contacted under polymerization conditions with a slurry of a catalyst composition in at least one hydrocarbon. The catalyst composition comprises a Group 4 metal complex of a phenolate ether ligand and the slurry includes from about 5 to less than 40 ppm per liter of a compound effective to increase the conductivity of said at least one hydrocarbon. | 2013-04-11 |
20130090431 | STORAGE-STABLE HEAT-ACTIVATED TERTIARY AMINE CATALYSTS FOR EPOXY RESINS - Epoxy adhesive compositions contain a heat-activatable catalyst. The heat-activatable catalyst includes a tertiary amine catalyst and a novolac resin that has a weight average molecular weight of at least 3000. One-component epoxy adhesive formulations that contain the heat-activatable catalyst have unexpectedly good storage stability. | 2013-04-11 |
20130090432 | ALKOXYLATED POLYMERS - A process for the preparation of alkoxylated polymers comprising the steps (i) preparation of a polymeric product (I) having at least one functional group by radical copolymerization in a high temperature polymerization process and (ii) contacting the polymeric product (I) having at least one functional group obtained in step (i) with at least one alkylene oxide; an alkoxylated polymer obtainable by the process of the present invention; a process for preparing polyurethanes by reaction of the alkoxylated polymer according to the present invention; polyurethane prepared by the process of the present invention; surface active reagents comprising or consisting of the alkoxylated polymer according to the present invention as well as detergent formulations comprising at least one alkoxylated polymer according to the present invention. | 2013-04-11 |
20130090433 | Modified Polyethylene Compositions - The present invention relates to a branched modifier and a composition comprising more than 25 wt % (based on the weight of the composition) of one or more linear ethylene polymers having a g′ | 2013-04-11 |
20130090434 | AZIRIDINYL-CONTAINING COMPOUNDS - Compounds are described that have both an aziridinyl group as well as a polymeric group. Methods of making these compounds are also described. The aziridinyl group of the compound can be reacted with an acidic group on a second compound resulting in the opening of the aziridinyl ring and the attachment of the polymeric group to the second compound. | 2013-04-11 |
20130090435 | POWDER COATINGS COMPOSITIONS - A solid epoxy resin powder coating composition which includes a divinylarene dioxide resin as one component; and wherein the solid epoxy resin powder coating composition can be formed by blending or reacting various other components with the divinylarene dioxide resin. For example, other components can include other epoxy resins; phenolic resins; or monomeric and/or polymeric isocyanates. The powder coating composition or formulation may advantageously provide, for example, a Fusion Bonded Epoxy coating on a substrate. | 2013-04-11 |
20130090436 | Process for the Gas-Phase Polymerization of Olefins - A process for the gas-phase copolymerization of: (a) propylene, (b) at least one C | 2013-04-11 |
20130090437 | CATALYST SUPPORTS, CATALYSTS AND THEIR MANUFACTURE AND USE - A process for preparation of silica xerogel catalyst support particles having high surface areas involves ageing a silica hydrogel at a pH from 3 to 5 and at a temperature of 45° C. or more. The ageing at low pH leads to a silica gel which may be converted to a xerogel having a pore volume of 1.5 cm | 2013-04-11 |
20130090438 | PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT POLYETHYLENE - In a process for producing polyethylene having a molecular weight of at least 3×10 | 2013-04-11 |
20130090439 | Polymerization Of 2,3,3,3-Tetrafluoropropene And Polymers Formed From 2,3,3,3-Tetrafluoropropene - The present invention relates to methods of producing polymerized 2,3,3,3-tetrafluoropropene (poly-1234yf) using one or a combination of the techniques provided herein. In certain embodiments, such techniques include (1) emulsion polymerization; (2) suspension polymerization; (3) solution polymerization; (4) supercritical carbon dioxide polymerization; (5) transition metal catalyzed polymerization; (6) radiation or thermal polymerization; and combinations thereof. A wide array of initiators, catalysts, and solvents may be used in such polymerization processes and may include, but are not limited to, (1) radical initiators; (2) ionic initiators; and (3) single-site and multiple-site catalysts. | 2013-04-11 |
20130090440 | LOW VINYL STYRENE-BUTADIENE POLYMERS AND METHODS OF MAKING THE SAME - The invention provides a process for the continuous polymerization of a polymer comprising monomeric units derived from styrene and 1,3-butadiene, said process comprising:
| 2013-04-11 |
20130090441 | POLYMERIZABLE COMPOSITIONS FREE OF ORGANIC EMULSIFIER AND POLYMERS AND METHODS OF MAKING THEREOF - Described herein is a polymerizable composition substantially free of an organic emulsifier, methods of making, and articles thereof. The polymerizable composition comprises: a continuous phase; a polymerizable monomer; an initiator; and inorganic nanoparticles, wherein the inorganic nanoparticles are substantially free of groups that will copolymerize with the polymerizable monomer. | 2013-04-11 |
20130090442 | SYNTHESIS OF HYPERBRANCHED POLYACRYLATES BY EMULSION POLYMERIZSATION OF INIMERS - A method for the production of hyperbranched polyacrylates includes the step of reacting acrylic inimers through controlled living polymerization in aqueous conditions. The inimers may have the formula: | 2013-04-11 |
20130090443 | POLYMERIZABLE CARBAMATE AND THIOCARBAMATE COMPOUNDS, POLYMERS DERIVED FROM THEM, AND COMPOSITIONS THEREOF - Carbamate and thiocarbamate compounds are described that comprise a polymerizable moiety and one or more free hydroxyl and/or thiol groups. Polymers may be obtained by polymerizing these carbamate and/or thiocarbamate compounds. The carbamate and thiocarbamate compounds, as well as the polymers they produce may be formulated into adhesive, agricultural, biocide, cleaning, coating, encapsulation, membrane, oilfield, performance chemical, and personal care compositions. | 2013-04-11 |
20130090444 | POLAR, MULTI-HYDROXYL FUNCTIONAL AMINO COMPOUNDS, COMPOSITIONS, PROCESS FOR PREPARATION, THEIR USES & APPLICATIONS - A compound which is the Michael addition reaction product of (A) a mono or polyacrylate of the formula R | 2013-04-11 |
20130090445 | SYNTHESIS SYSTEM, RUBBER CHEMICAL SUBSTANCE FOR TIRES, SYNTHETIC RUBBER FOR TIRES, AND PNEUMATIC TIRE - The present invention provides a synthesis system that can synthesize aniline and/or styrene efficiently, a synthesis system that can synthesize butadiene (1,3-butadiene) efficiently, a rubber chemical for a tire which is synthesized from the aniline obtained by the synthesis system, a synthetic rubber for a tire which is synthesized from the styrene and/or butadiene obtained by the synthesis systems, and a pneumatic tire produced using the rubber chemical for a tire and/or the synthetic rubber for a tire. The present invention relates to a synthesis system for synthesizing aniline and/or styrene from an alcohol having two or more carbon atoms via an aromatic compound. | 2013-04-11 |
20130090446 | POLYMER CONTAINING UNITS OF FLUORENE, ANTHRACENE AND BENZOTHIADIAZOLE, PREPARATION METHOD THEREOF AND APPLICATION THEREOF - A polymer containing units of fluorene, anthracene and benzothiadiazole with the following formula is provided: | 2013-04-11 |
20130090447 | TYPICAL METAL CONTAINING POLYSILOXANE COMPOSITION, PROCESS FOR ITS PRODUCTION, AND ITS USES - A material suitable for sealing an LED element or for a gas barrier layer for a resin component, and an LED device, an FPD device and a semiconductor device using it. A process for producing a polymer composition, which includes mixing and reacting as component (A), an unsaturated group-containing siloxane compound of the following formula (1): | 2013-04-11 |
20130090448 | WATER-REPELLENT FINE PARTICLES AND MAKING METHOD - Silicone elastomer spherical particles having a volume mean particle size of 0.1-100 μm are coated with a polyorganosilsesquioxane and washed with alcohol or a mixture of alcohol and water. The coated fine particles are water repellent so that they are non-dispersible in water and float on water. | 2013-04-11 |
20130090449 | Biobased Polyester Diols And Polyols From High Molecular Weight Polyhydroxyalkanoates - Methods for producing biobased hydroxyl-terminated polyester polymers are described wherein molten-dispersed or hydrocarbonaceous fluid-dispersed phase polyhydroxyalkanoate polymers are reacted with a difunctional hydroxylated insertion compound at a sufficient temperature and time to depolymerize the starting polyester polymers to provide hydroxyl-terminated reaction products of reduced molecular weight. The difunctional hydroxylated insertion compound can be at least one of diol, aminoalcohol, and polyhydroxyalcohol. The use of catalyst may be required, reduced or eliminated. The hydroxyl-terminated reaction product is at least one of hydroxyl-terminated polyhydroxyalkanoate. A method for making polyurethanes further is described wherein the hydroxyl-terminated reaction product is reacted with polyfunctional isocyanate to form a polyurethane product. Products that include the hydroxyl-terminated reaction product or polyurethane also are described. | 2013-04-11 |
20130090450 | ACCELERATORS FOR POLYMERIZATION OF EPOXY RESINS - Embodiments of the present invention disclose accelerator compositions useful in the curing of an epoxy resins having at least one amine and a glycerin. | 2013-04-11 |
20130090451 | POLYLACTIDE RESIN HAVING EXCELLENT HEAT RESISTANCE AND PREPARATION METHOD THEREOF - The present invention relates to a polylactide resin having excellent heat resistance, a preparation method thereof, and a polylactide resin composition including the same. | 2013-04-11 |
20130090452 | PROCESS FOR PREPARING EDDN AND/OR EDMN BY CONVERSION OF FACH AND EDA - A process for reacting formaldehyde cyanohydrin (FACH) with ethylenediamine (EDA) in a reactor with limited backmixing at a temperature in the range from 20 to 120° C., wherein the residence time in the reactor is 300 seconds or less. | 2013-04-11 |
20130090453 | Process for preparing TETA and DETA - A process for preparing TETA and/or DETA by hydrogenating EDDN and/or EDMN with hydrogen in the presence of a catalyst, which comprises preparing EDDN and/or EDMN from FA, HCN and EDA in the presence of toluene as a solvent and performing the hydrogenation in suspension mode in the presence of THF. | 2013-04-11 |
20130090454 | Light-Sensitive Ion-Passing Molecules - The invention provides polynucleotides and methods for expressing light-activated proteins in animal cells and altering an action potential of the cells by optical stimulation. The invention also provides animal cells and non-human animals comprising cells expressing the light-activated proteins. | 2013-04-11 |
20130090455 | TRANSFORMANT WHICH PRODUCES GLYCINE REPEAT SEQUENCE PROTEIN - Disclosed is a transformant in which polynucleotides comprising a nucleotide sequence encoding the amino acid sequence of all of the following proteins (1) to (3) are transfected into a microbial cell:
| 2013-04-11 |
20130090456 | METHODS FOR IDENTIFYING IMMUNOBINDERS OF CELL-SURFACE ANTIGENS - The invention provides methods for identifying immunobinders, such as scFv antibodies, capable of specifically binding to cell surface antigens, and compositions identified according to said methods. | 2013-04-11 |
20130090457 | Toll-Like Receptor 3 Antagonists for the Treatment of Metabolic and Cardiovascular Diseases - Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed. | 2013-04-11 |
20130090458 | Immunoconjugates with an Intracellularly-Cleavable Linkage - The present invention relates to therapeutic conjugates with improved ability to target various diseased cells containing a targeting moiety (such as an antibody or antibody fragment), a linker and a therapeutic moiety, and further relates to processes for making and using the conjugates. | 2013-04-11 |
20130090459 | METAL-ASSISTED AND MICROWAVE-ACCELERATED EVAPORATIVE CRYSTALLIZATION - The present invention relates to methods for rapid crystallization of amino acids, drug molecules, proteins and DNA/peptides. One method for rapid crystallization of functional group-containing molecules selected from the group consisting of amino acids, drug molecules, proteins and DNA/peptides includes (A) providing at least one metal or metal oxide in particulate or thin film form to provide (a) selective nucleation sites for crystallization of the functional group-containing molecules due to interactions of their functional groups and metal surfaces or engineered metal surfaces and (b) a microwave-transparent medium to create a thermal gradient between the metal surfaces or engineered metal surfaces and a warmer solution containing functional group-containing molecules to be crystallized, and (B) conducting microwave heating to cause the functional group-containing molecules to be crystallized. | 2013-04-11 |
20130090460 | RARE EARTH METAL COMPLEX - A rare earth metal complex including a rare earth element and a β-diketone compound represented by the following formula (1) as a ligand, and in formula (1), R | 2013-04-11 |
20130090461 | NEW COMPOUND SMILAXCHINOSIDE F - Smilaxchinoside F compound and its separation method are disclosed. The compound has the structure as following. The use of Smilaxchinoside F in the manufacture of a medicine for treating abnormal angiogenesis and its relating diseases is also disclosed. | 2013-04-11 |
20130090462 | WHEAT WITH INCREASED RESISTANT STARCH LEVELS - A series of independent human-induced non-transgenic mutations found at one or more of the SBEII genes of wheat; wheat plants having these mutations in one or more of their SBEII genes; and a method of creating and finding similar and/or additional mutations of SBEII by screening pooled and/or individual wheat plants. The seeds and flour from the wheat plants of the present invention exhibit an increase in amylose and resistant starch without having the inclusion of foreign nucleic acids in their genomes. Additionally, the wheat plants of the present invention exhibit altered SBEII activity without having the inclusion of foreign nucleic acids in their genomes. | 2013-04-11 |
20130090463 | POLYNUCLEOTIDES HAVING PROMOTER ACTIVITY - The present invention relates to isolated polynucleotides having promoter activity the juse of the isolated polynucleotides for the procuction of a polypeptide. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing a desired polypeptide using the polypeptide having promoter activity. | 2013-04-11 |
20130090464 | Process Using Dual Specificity Oligonucleotide and Dual Specificity Oligonucleotide - The present invention relates to various processes by a template-dependent extension reaction using a dual specificity oligonucleotide and a dual specificity oligonucleotide composed of three different Tm portions therefor. Demonstrated in the present invention are the features of the dual specificity oligonucleotide, which are high hybridization specificity and mismatch tolerance. | 2013-04-11 |
20130090465 | ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS - Oligonucleotides having a nucleotide sequence complementary to nucleotide numbers such as 2571-2607, 2578-2592, 2571-2592, 2573-2592, 2578-2596, 2578-2601 or 2575-2592 of the dystrophin cDNA (Gene Bank accession No. NM_004006.1) and therapeutic agents for muscular dystrophy comprising such oligonucleotides. | 2013-04-11 |
20130090466 | CRYSTALLIZATION PROCESS OF CYCLIC ADENOSINE 3',5'-MONOPHOSPHATE - Provided is a crystallization process of cyclic adenosine 3′,5′-monophosphate, which comprises the following steps: 1) reacting an aqueous solution of cyclic adenosine 3′,5′-monophosphate with a base to obtain a salt of cyclic adenosine 3′,5′-monophosphate; 2) reacting the cyclic adenosine 3′,5′-monophosphate salt solution obtained in step 1) with an acid to obtain cyclic adenosine 3′,5′-monophosphate; 3) keeping cyclic adenosine 3′,5′-monophosphate obtained in step 2) at 0-15° C. | 2013-04-11 |
20130090467 | APTAMER BIOCONJUGATE DRUG DELIVERY DEVICE - A delivery device for an active agent comprises nanoparticles based on a biopolymer such as starch. The delivery device may also be in the form of an aptamer-biopolymer-active agent conjugate wherein the aptamer targets the device for the treatment of specific disorders. The nanoparticles may be made by applying a high shear force in the presence of a crosslinker. The particles may be predominantly in the range of 50-150 nm and form a colloidal dispersion of crosslinked hydrogel particles in water. The biopolymer may be functionalized. The aptamer may be conjugated directly to the cross-linked biopolymers. The active agent may be a drug useful for the treatment of cancer. The delivery device survives for a period of time in the body sufficient to allow for the sustained release of a drug and for the transportation and uptake of the conjugate into targeted cells. However, the biopolymer is biocompatible and resorbable. | 2013-04-11 |
20130090468 | METHANESULFONATE SALTS OF ABIRATERONE-3-ESTERS AND RECOVERY OF SALTS OF ABIRATER ONE-3-ESTERS FROM SOLUTION IN METHYL TERT-BUTYL ETHER - A salt of a compound of formula (I) may be made with methanesulfonic acid. The salt and salts with other acids may be prepared by recovering from methyl tert-butyl ether (MTBE). | 2013-04-11 |
20130090469 | GREEN ZINC PORPHYRIN SENSITIZERS AND THEIR APPLICATIONS - The present invention relates to zinc porphyrin-based photosensitive dyes, specifically to zinc porphyrin-based photosensitive dyes with green transparency. The photosensitive dyes exhibit high push-pull ability in the zinc porphyrin-based structure, higher absorption and power conversion efficiency. The photosensitive dyes are used in the manufacture of dye-sensitive solar cells. | 2013-04-11 |
20130090470 | OPTICALLY-DETECTABLE ENZYME SUBSTRATES AND THEIR METHOD OF USE - The present invention relates to compounds that are substrates for an enzyme, and upon reaction with the enzyme provide a detectable response, such as an optically detectable response. In particular, the compounds have utility in detecting the presence of a β-lactamase in a sample. In addition to the compounds, methods are disclosed for analyzing a sample for the presence of a β-lactmase, for example, as an indicator of expression of a nucleic acid sequence including a sequence coding for a β-lactmase. Kits are disclosed that include the disclosed compounds and additional components, for example, cells, antibodies, a β-lactmase or instructions for using the components in an assay. | 2013-04-11 |
20130090471 | METHOD FOR DETECTING COMPOUNDS THAT MODULATE THE CHOLESTEROL METABOLISM - The present invention relates to a method for identifying compounds that modulate cholesterol metabolism by detecting enzyme activities involved in the synthesis or catabolism of cholesterol. Said method enables the lethal risk for mammalian cells when the cholesterol level decreases to be avoided, due to the use of genetically modified yeasts, the survival of which is not strictly dependent upon the cholesterol production. | 2013-04-11 |
20130090472 | GOLD COMPLEXES FOR USE IN THE TREATMENT OF CANCER - The invention provides compounds of the Formula (I), in which W is independently selected from W | 2013-04-11 |
20130090473 | Methods for preparing anti-viral nucleotide analogs - Methods for isolating 9-{(R)-2-[((S)-{[(S)-1-(isopropoxycarbonyl)ethyl]amino}phenoxyphosphinyl)methoxy]propyl}adenine (compound 16): | 2013-04-11 |
20130090474 | PROCESS FOR THE PREPARATION OF PTERIDINE DERIVATIVES - The application discloses a process for the preparation of 5-deoxy-L-arabinose of formula (VI); comprising the conversion of a compound of formula (XII); wherein n is 0, 1 or 2; which can be used as intermediate for the synthesis of sapropterin. | 2013-04-11 |
20130090475 | Process for the Preparation of Ranolazine - A process for the preparation of ranolazine comprises the step of condensing N-(2,6-dimethylphenyl)-1-piperazinyl acetamide with a compound of formula (I) to obtain ranolazine, in which X is chlorine or bromine Ranolazine is prepared by condensing ring-opening halide which replaces epoxide in this process. | 2013-04-11 |
20130090476 | Thiazolylpiperidine Derivatives as Fungicides - Thiazolylpiperidine derivatives of the formula (I), | 2013-04-11 |
20130090477 | Thiazolylpiperidine Derivatives as Fungicides - Thiazolylpiperidine derivatives of the formula (I), | 2013-04-11 |
20130090479 | THIAZOLES, IMIDAZOLES, AND PYRAZOLES USEFUL AS INHIBITORS OF PROTEIN KINASES - The present invention relates to compounds useful as inhibitors of protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising said compounds and methods of using the compounds and the compositions in the treatment of various disease, conditions, or disorders. The invention also relates to processes for preparing compounds of the inventions. | 2013-04-11 |
20130090480 | Benzoxazole Derivatives Having Inhibitory Activity Against Interleukin-6, Preparation Method Thereof, and Pharmaceutical Composition Containing the Same - The present invention relates to benzoxazole derivatives represented by the Formula 1, which has an inhibitory activity against interleukin-6 (IL-6), a method for preparation thereof, and a pharmaceutical composition containing the same. The compound represented by the Formula 1 according to the present invention has a superior inhibitory activity against interleukin-6, and therefore, can be practically applied for prevention and treatment of diseases caused by abnormal interleukin-6 activity. | 2013-04-11 |
20130090481 | Sulfonated dye salts exhibiting reduced kogation - A sulfonated dye salt of formula (II): | 2013-04-11 |
20130090482 | CRYSTALLINE FORMS OF 4, 4'- [4-FLUORO-7-( ETHYNYL)-2-METHYL-1H-INDOLE-1,3-DIYL] DIBUTANOIC ACID, 4,4'-[2-METHYL-7-( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID, AND 4,4'-[4-FLUORO-2-METHYL-7- ( ETHYNYL)-1H-INDOLE-1, 3-DIYL] DIBUTANOIC ACID - The present invention provides type C crystal of compound I, type B crystal of compound II, or type C crystal of compound III set forth in this specification. | 2013-04-11 |
20130090483 | SYNTHETIC PROCESSES FOR THE PREPARATION OF AMINOCYCLOHEXYL ETHER COMPOUNDS - This invention is directed to stereoselective synthesis of compounds of formula (I) or formula (II): | 2013-04-11 |
20130090484 | PROCESS FOR MAKING AN INTERMEDIATE OF CABAZITAXEL - A novel process of making 7,10-dialkyl-10-DAB of formula (I) | 2013-04-11 |
20130090485 | METHOD FOR PREPARING CHLOROHYDRINS AND METHOD FOR PREPARING EPICHLOROHYDRIN USING CHLOROHYDRINS PREPARED THEREBY - A method of preparing chlorohydrins and a method of preparing epichlorohydrin by using chlorohydrins prepared using the method are provided. The method of preparing chlorohydrins by reacting polyhydroxy aliphatic hydrocarbon with a chlorination agent in the presence of a catalyst includes at least one combination of a series of unit operations including a first reaction step, a water removal step, and a second reaction step, in that respective order, and after mixing at least a portion of a reaction mixture discharged from at least one reaction steps from among the plurality of reaction steps with an additional chlorination agent, recirculating the resulting mixture to the reaction step from which the reaction mixture was discharged. The method of preparing epichlorohydrin includes a step of reacting chlorohydrins prepared using the method of preparing chlorohydrins, with an alkaline agent. | 2013-04-11 |
20130090486 | Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol - A method of purifying 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol to obtain 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol in crystalline form using precipitation with hexane from ethyl acetate. A method of preparing 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol crystals acceptable for X-ray experiment using precipitation with hexane from benzene by diffusive exchange of the solvents is also described. | 2013-04-11 |
20130090487 | PROCESS FOR THE PRODUCTION OF BIO-OIL FROM MUNICIPAL SOLID WASTE - A process for producing bio-oil from municipal solid waste, the process including: a) liquifying municipal solid waste, to obtain a mixture containing an oily phase containing bio-oil, a solid phase, and a first aqueous phase; b) treating the first aqueous phase from a) with an adsorbing material, to obtain a second aqueous phase; c) fermenting the second aqueous phase from b), to obtain a biomass; d) subjecting the biomass obtained in c) to the liquification a). The bio-oil obtained is advantageously used in the production of biofuels for motor vehicles or for the generation of electric energy or heat. | 2013-04-11 |
20130090488 | DEVICE AND METHOD FOR SOLUBILIZING, SEPARATING, REMOVING AND REACTING CARBOXYLIC ACIDS IN OILS, FATS, AQUEOUS OR ORGANIC SOLUTIONS BY MEANS OF MICRO-OR NANOEMULSIFICATION - The present invention is directed to solubilizing compounds, a device and a method for solubilizing and removing carboxylic acids and especially fatty acids from oils, fats, aqueous emulsion, aqueous media and organic solutions. Devices utilizing the inventive method shall be used for separating carboxylic acids from oils, fats, aqueous emulsion, lipophilic media or organic solutions, respectively by preparing an aqueous micro- or nanoemulsion of the carboxylic acids especially the fatty acids and the solubilizing compound which contains at least one amidino and/or gianidino group. Solubilization effects of solubilizing compounds combined with the inventive use of separation methods for carboxylic acids can be used to treat persons in need of removal of fatty acids or analyze carboxylic acids from blood or process other solutions in food, pharmacy, chemistry, bio fuel industry or other industrial processings. | 2013-04-11 |
20130090489 | CATALYTIC PROCESS FOR PHOSPHO-HALOGENATION OF FLUORINATED ALCOHOLS - A process for manufacturing a polyfluroalkanoyl phosphorodichloridate comprising reacting a polyfluoroalkanol having the general formula R | 2013-04-11 |
20130090490 | METHOD FOR PRODUCING AROMATIC DIPHOSPHATES - A method for producing an aromatic diphosphate comprising: Step 1 which is a step where a specific aromatic monohydroxy compound having a steric hindrance group at ortho-positions is made to react with phosphorus oxyhalide in the presence of a Lewis acid catalyst and then the unreacted phosphorus oxyhalide is removed under a reduced pressure to give a specific; and Step 2 which is a step where the reaction product obtained in the above step is made to react with a specific aromatic dihydroxy compound in an amount of 0.5 mol to 1 mol of halogen contained in the reaction product in the presence of a Lewis acid catalyst to give a specific aromatic diphosphate. | 2013-04-11 |
20130090491 | PHENOL-FREE PHOSPHITES DERIVATIVES AND PREPARATION THEREOF - The present invention relates to phenol-free phosphites and preparation thereof. The phenol-free phosphites are obtained by reacting biphenol, and phosphorous derivatives with higher aliphatic alcohol via condensation and trans-esterification. The phenol-free phosphites of the present invention can be used as a heat stabilizer for resin so as to enhance the heat resistance of the resin during processing at high temperatures. | 2013-04-11 |
20130090492 | TRANSESTERIFICATION PROCESS USING MIXED SALT ACETYLACETONATES CATALYSTS - This invention is directed to a general catalyst of high activity and selectivity for the production of a variety of esters, particularly acrylate and methacrylate-based esters, by a transesterification reaction. This objective is achieved by reaction of an ester of a carboxylic or a carbonic acid, in particular of a saturated or unsaturated, typically, a 3 to 4 carbon atom carboxylic acid; with an alcohol in the presence of a catalyst comprising the combination of a metal 1,3-dicarbonyl complex (pref. Zn or Fe acetylacetonate) and a salt, in particular an inorganic salt, pref. ZnCl2, LiCI, NaCI, NH4CI or Lil. These catalysts are prepared from readily available starting materials within the reaction medium without the need for isolation (in-situ preparation). | 2013-04-11 |
20130090493 | PROCESS FOR THE PREPARATION OF ISOSERINE DERIVATIVES - This invention relates to a “one pot” process for the preparation of isoserine derivatives in high diastereoselective way. The process according to the invention includes the steps of reacting a protected glycidic acid with imines to yield isoserines protected both at the —OH and at the —COOH groups, deprotection of the obtained intermediates to isoserines or isoserine 1-4C— alkyl esters. Pure threo derivatives as the main isomer are obtained. | 2013-04-11 |
20130090494 | TETRAKIS[BIS(DIHYDROXYPHOSPHORYL)METHYL]CALIX[4]ARENE OR ITS SODIUM SALT THEREOF AS FIBRIN POLYMERIZATION INHIBITORS - There is proposed a chemical compound of 5,11,17,23-tetrakis[bis(dihydroxyphosphoryl)methyl]calix[4]arene and a sodium salt thereof, which can be used as antithrombotic agents. A highly specific inhibiting effect of the aforementioned calixarenes on the fibrin polymerization has been identified. It has been found that the addition of the aforementioned calixarenes to blood plasma leads to an increase of the prothrombin time and the activated partial thromboplastin time. | 2013-04-11 |
20130090495 | SELECTIVE HYDROCARBON OXIDATION USING HETEROGENOUS CATALYSTS - A process for the complete or partial oxidation of hydrocarbons comprises contacting a C | 2013-04-11 |
20130090496 | PROCESS FOR PREPARING FORMIC ACID BY REACTING CARBON DIOXIDE WITH HYDROGEN - The invention relates to a process for preparing formic acid by reacting carbon dioxide with hydrogen in a hydrogenation reactor in the presence of a catalyst comprising an element of group 8, 9 or 10 of the Periodic Table, a tertiary amine and a polar solvent to form formic acid-amine adducts which are subsequently dissociated thermally into formic acid and tertiary amine. | 2013-04-11 |
20130090497 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM - A method producing a surfactant from glycerol by converting glycerol, in a first step, to glycidol, polymerizing glycidol to an aliphatic alcohol and finally substituting a hydroxyl group with a substitute anion. | 2013-04-11 |
20130090498 | PROCESSES FOR PRODUCING 4-BROMO-2-METHOXYBENZALDEHYDE - A new synthesis of 4-bromo-2-methoxybenzaldehyde is reported from 1,4 dibromo 2-fluorobenzene. First, 2-fluoro-4-bromobenzaldehyde is prepared through metal halogen exchange and formylation with a formyl source at 0° C. After crystallization, this intermediate is reacted with methanol in the presence of potassium carbonate. Subsequently, 4-bromo-2-methoxy-benzaldehyde is crystallized. | 2013-04-11 |
20130090499 | Cyclohexanone Dehydrogenation Catalyst and Process - A catalyst composition comprising: (i) a support; (ii) a first component comprising at least one metal component selected from Group 1 and Group 2 of the Periodic Table of Elements; and (iii) a second component comprising at least one metal component selected from Groups 6 to 10 of the Periodic Table of Elements, wherein the catalyst composition exhibits an oxygen chemisorption of greater than 50%. | 2013-04-11 |
20130090500 | PROCESSES FOR HYDROGENATING ALKANOIC ACIDS USING CATALYST COMPRISING TUNGSTEN - A process hydrogenating alkanoic acids in the presence of a catalyst that comprises supports, one or more metals, tungsten oxide, and at least one alkaline earth metal oxide or metasilicate. The molar ratio of the at least one alkaline earth metal oxide or metasilicate to tungsten oxide, based on the metals, is from 1:3 to 5:1. | 2013-04-11 |
20130090501 | PROCESS FOR PRODUCING ETHANOL USING A CRUDE VINYL ACETATE FEED - Converting a crude vinyl acetate feed to ethanol by hydrogenating the acetic acid and ethyl acetate in the crude vinyl acetate feed. The crude vinyl acetate feed may comprise acetic acid and/or ethyl acetate, as well as vinyl acetate and minor amounts of vinyl propionate. The crude vinyl acetate feed may be obtained from an azeotrope column as either a sidestream or a bottom stream in a vinyl acetate production process. | 2013-04-11 |
20130090502 | PROCESS FOR MANUFACTURE OF LIQUID FUEL COMPONENST FROM RENEWABLE SOURCES - A method for producing liquid fuel components from renewable oil. A fresh feedstock including saturated fatty acids is subjected to dilution by an organic lipophilic solvent. The solvent has a low phosphorus and metal impurity content, less than 5 ppm and less than 10 ppm, respectively. Dilution is performed before and/or during purification by at least one pretreatment process for removal of phosphorus and metal impurities. Subsequently, the resulting purified feedstock is fed into at least one post-treatment process suitable for producing liquid fuel components. | 2013-04-11 |
20130090503 | Process for Alkane Oligomerization - Provided is a process for preparing oligomers from an alkane. The process comprises (a) contacting an alkane under dehydrogenation conditions in the presence of a dehydrogenation catalyst such as an iridium catalyst complex comprising iridium complexed with a benzimidiazolyl-containing ligand to form olefins, and (b) contacting the olefins prepared in step (a) under oligomerization conditions with an oligomerization catalyst such as a nickel, platinum or palladium metal catalyst complex comprising the metal complexed with a nitrogen containing bi- or tridentate ligand to prepare oligomers of the olefins, and hydrogenating the olefin oligomers. In one embodiment, the ligands of the catalyst complexes in step (a) and step (b) can be the same. | 2013-04-11 |
20130090504 | Methane Enrichment of a Gaseous Alkane Stream for Conversion to Liquid Hydrocarbons - A method is provided for converting gaseous lower molecular weight alkanes contained in a feed gas to liquid higher molecular weight hydrocarbons. One or more lower molecular weight alkanes contained in the feed gas, which are heavier than methane, are converted to methane in a pre-former reactor. The resulting methane-enriched gas has a methane fraction greater than the methane fraction of the feed gas. The methane-enriched gas and bromine are reacted to form alkyl bromide and the alkyl bromide is reacted in the presence of a catalyst to form the liquid higher molecular weight hydrocarbons and a residual gas. The liquid higher molecular weight hydrocarbons are recovered as product and the residual gas is fed to the pre-former reactor with the feed gas. | 2013-04-11 |
20130090505 | APPARATUS AND PROCESS FOR TREATING NATURAL GAS - A process is described for treating a natural gas stream containing methane and one or more higher hydrocarbons including the steps of:
| 2013-04-11 |
20130090506 | METHOD FOR PRODUCING AROMATIC HYDROCARBON - When producing an aromatic hydrocarbon by a contact reaction of a lower hydrocarbon with a catalyst, the aromatic hydrocarbon is produced stably for a long time while maintaining a high aromatic hydrocarbon yield. | 2013-04-11 |
20130090507 | MULTIPLE ZEOLITE CATALYST AND METHOD OF USING THE SAME FOR TOLUENE DISPROPORTIONATION - The multiple zeolite catalyst is a catalytic composition used to convert alkylaromatic hydrocarbons to BTX, particularly to commercially valuable xylenes. The catalyst is formed by mixing at least two zeolites selected from mordenite, beta zeolite, ZSM-5, ZSM-11, ZSM-12, ZSM-22, ZSM-23, MFI topology zeolite, NES topology zeolite, EU-1, MAPO-36, SAPO-5, SAPO-11, SAPO-34, and SAPO-41, and adding at least one metal component selected from Group VI of the Periodic Table of the Elements. The two zeolites have different physical and chemical characteristics, such as pore size and acidity. An exemplary catalyst includes mordenite, ZSM-5, and 3 wt % molybdenum. The multiple zeolite catalyst may further be used to convert toluene to mixed xylene isomers, particularly with a ZSM-5:mordenite ratio of 2:1 by weight. | 2013-04-11 |
20130090508 | Method for Preparing 1-Octene by Oligomerization of Ethylene - Disclosed is a method for preparing 1-octene in the presence of a catalyst system for ethylene oligomerization, which includes: premixing a part of ethylene gas as raw material with a solvent, mixing with the components a+b, c and d of the catalyst system, and then sending in a reactor; directly sending the rest of ethylene gas in the reactor; discharging the resultant liquid from the upper part of the reactor into an overflow channel; adding a catalysis stopping agent to the overflow channel; and then separating the resultant liquid. The advantages of the method are high selectivity of 1-octene and high catalytic activity. | 2013-04-11 |
20130090509 | Single-Step Precipitation Method of Producing Magnesia-zirconia Complex Carrier for Catalyst for Oxidative Dehydrogenation of n-Butane, Magnesium Orthovanadate Catalyst Supported on Magnesia-zirconia Complex Carrier, and Method of Producing n-Butene and 1,3-Butadiene Using Said Catalyst - The present invention discloses a method of producing a magnesia-zirconia complex carrier for a catalyst for oxidative dehydrogenation of n-butane through a single-step precipitation process wherein the oxidative dehydrogenation of n-butane is to produce n-butene and 1,3-butadiene from n-butane; a method of producing a magnesium orthovanadate catalyst supported by thus prepared magnesia-zirconia complex carrier; and a method of producing n-butene and 1,3-butadiene using said catalyst. | 2013-04-11 |
20130090510 | PROCESS FOR DEHYDRATION OF DILUTE ETHANOL INTO ETHYLENE WITH LOW ENERGY CONSUMPTION WITHOUT RECYCLING OF WATER - A process for dehydration of an ethanol feedstock into ethylene, comprising the vaporization of said dilute hydrated ethanol feedstock in an exchanger, with heat exchange with the effluent that is obtained from a last reactor, with said mixture being introduced into said vaporization stage at a pressure that is lower than the pressure of the effluent that is obtained from the last reactor, the compression of the mixture that is vaporized in a compressor, the introduction of the vaporized and compressed mixture, into at least one adiabatic reactor that contains at least one dehydration catalyst. | 2013-04-11 |
20130090511 | SYNTHESIS OF ULTRASMALL METAL OXIDE NANOPARTICLES - The invention generally relates to the ultrasmall MO | 2013-04-11 |
20130090512 | RESIN VOLUME REDUCTION PROCESSING SYSTEM AND RESIN VOLUME REDUCTION PROCESSING METHOD - The cost relating to a reduction in volume and storage of a waste resin including a radioactive nuclide is reduced. In an aspect of the invention, a volume reduction processing system | 2013-04-11 |
20130090513 | USE OF BORIC ACID IN BORON NEUTRON CAPTURE THERAPY FOR LIVER CANCER - The present invention provides a boron drug for boron neutron capture therapy for liver cancer, which is an aqueous solution of boric acid. | 2013-04-11 |
20130090514 | RADIATION THERAPY APPARATUS - A radiation therapy apparatus includes a gantry having a central aperture that defines a cavity, in which a patient is positionable. The apparatus also includes a positioning device, with which the patient is positionable in the central aperture of the gantry, and a radiation head for generating therapeutic radiation. The apparatus includes an extension mechanism for the radiation head. The extension mechanism may be operated, such that in a first operating mode, the radiation head is disposable inside the gantry, such that the gantry has, on a side facing the positioning device, a front surface that constitutes a front limit of the radiation therapy apparatus toward the positioning device. In the first operating mode, the radiation head is behind the front surface viewed from the positioning device. In a second operating mode, the radiation head, viewed from the positioning device, may be moved out in front of the front surface. | 2013-04-11 |
20130090515 | Therapeutic Furniture Covering System Using Magnets - A therapeutic furniture covering system using magnets for increasing the convenience of conducting therapy treatment in an individual's home. The furniture assembly houses embedded magnets used in the improvement of an individual's overall health: improvements in circulation, reduction of pain, and relief of osteoarthritis. While a user may rest, and simultaneously treat, an individual body member, whole-body therapy may be achieved by an individual resting his or her entire body on the furniture item within close proximity of the static magnetic field. | 2013-04-11 |
20130090516 | Local Anesthesia By Magnet-Directed Concentration of Nanoparticle Conjugated Anesthetic - Methods and formulations for induction of local anesthetic effects employing magnetic nanoparticles conjugated to anesthetic molecules. Magnetic nanoparticle-local anesthetic conjugates may be safely injected intravenously into human and animal subjects without encountering the deleterious effects observed with traditional injections of local anesthetics. The magnetic nanoparticle-local anesthetic conjugate may be concentrated at a site of action through the application of an external magnetic field to the patient at a site where local anesthesia is desired. | 2013-04-11 |
20130090517 | Flexible Protocol for an Implanted Prosthesis - The present application discloses systems and methods for transmitting configuration between a command module and a stimulation module of a hearing prosthesis. In accordance with at least some embodiments of the disclosed systems and methods, a hearing prosthesis determines that a block of configuration data is queued for transmission. In response to this determination, the hearing prosthesis divides the amount of queued configuration data into a plurality of configuration data fragments and transmits the data fragments separately. In some embodiments, the command module appends each configuration data fragment to a different packet of stimulation commands and transmits to the stimulation module appended stimulation packets. | 2013-04-11 |
20130090518 | BONE CONDUCTION IMPLANT - A bone conduction implant, including a bone fixture including a male screw section configured to screw into a skull and an abutment configured to be rigidly attached to the bone fixture, wherein the abutment includes an exterior surface diameter lying on a first plane normal to a longitudinal axis of the bone conduction implant that is less than or substantially equal to the maximum thread diameter of the male screw section of the bone fixture. | 2013-04-11 |
20130090519 | APPARATUS AND METHOD FOR THE CONDITIONED DESYNCHRONIZED NON-INVASIVE STIMULATION - A device with a non-invasive first stimulation unit configured to generate first stimuli which, when administered to a patient, suppress a pathologically synchronous activity of neurons in at least one of the brain, and the spinal cord of the patient, with a non-invasive second stimulation unit configured to generate at least one of optical, acoustic, tactile, vibratory, and thermal second stimuli, and with a control unit configured to control the first and second stimulation units, wherein the generation of the first and second stimuli takes place optionally in a first or a second operating mode, and the control unit is configured to control the first and second stimulation units in such a way that, in the first operating mode, the generation of at least 60% of the second stimuli is coupled in time to the generation of the first stimuli and, in the second operating mode, the generation of at least 60% of the second stimuli takes place without the generation of the first stimuli. | 2013-04-11 |
20130090520 | Bone Conduction Apparatus and Multi-sensory Brain Integration Method - The present disclosure provides a therapeutic method applicable to learning, attention, cognitive and developmental disorders. This method combines auditory, visual and vestibular stimuli into a systematic method which can be customized to address individual learning, attention and processing disorders. This method may be wirelessly implemented in a group setting. A device for providing vestibular and somatosensory stimulation through bone conduction of sound waves to skeletal bones is provided in the form of a pad that is applied to or wrapped around the individual in treatment, which is comfortable in use and may contain particulate filler material capable of providing bone conduction stimulation adjacent to the location of a bone conduction transducer and expand the sound conduction site over a larger area. | 2013-04-11 |
20130090521 | TIMED-RELEASE TENSIONED OR COMPRESSED FIBERS - A timed-release tensioned core-shell fiber comprises a core positioned within a shell. The shell is configured to hold the core under said tension or compression. The shell is at least partially removable and releases at least a portion of the tension or compression of the core in response to the shell being removed. The shell is at least partially removable by erosion or degradation due to mechanical, chemical, electrical, physical, or thermal processes, or combinations thereof. In some embodiments, the erosion or degradation of the shell may include biodegradation, bioerosion, photooxidation, or photodegradation. A fiber mesh comprised of core-shell fibers may be tuned for timed release of contraction or expansion forces in response to timed release of tension or compression of the core. The fiber mesh may be used in a medical device, bandage, implant, tissue construct, or sling. A suture may also comprise a core-shell fiber. | 2013-04-11 |
20130090522 | METHOD AND MATERIALS FOR PRODUCING A GENETICALLY MODIFIED ANIMAL - Transgenic artiodactyls are described as well as methods of making and using such artiodactyls. | 2013-04-11 |
20130090523 | REMOTE PERICARDIAL HEMOSTASIS FOR VENTRICULAR ACCESS AND RECONSTRUCTION OR OTHER ORGAN THERAPIES - Embodiments described herein provide devices, systems, and methods that reduce the distance between two locations in tissue, often for treatment of congestive heart failure. For example, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. The anchor may be deployed into the heart through a working lumen of a minimally invasive access tool. The minimally invasive access tool may have a plurality of grippers near a distal end of the working lumen. The grippers may engage epicardial tissue of the heart and may be moved radially inwardly relative so as to provide stabilization of the epicardial tissue and/or hemostasis near an access site where the anchor is inserted through the epicardium. The minimally invasive access tool may minimize blood loss from the access site and improve anchor implant processes. | 2013-04-11 |
20130090525 | NEURAL INTERFACE SYSTEM WITH AN EDGE ARRAY - The neural interface system of one embodiment includes a cylindrical shaft, a lateral extension longitudinally coupled to at least a portion of the shaft and having a thickness less than a diameter of the shaft, and an electrode array arranged on the lateral extension and radially offset from the shaft, including electrode sites that electrically interface with their surroundings. The method of one embodiment for making the neural interface system includes forming a planar polymer substrate with at least one metallization layer, patterning on at least one metallization layer an electrode array on a first end of the substrate, patterning conductive traces on at least one metallization layer, rolling a portion of the substrate toward the first end of the substrate, and securing the rolled substrate into a shaft having the first end of the substrate laterally extending from the shaft and the electrode array radially offset from the shaft. | 2013-04-11 |
20130090526 | ANASTOMOSIS SYSTEM - There is provided an endoscopic system. | 2013-04-11 |
20130090527 | COVERING FOR A MEDICAL SCOPING DEVICE - The present invention relates to a cover having a plurality of moveable, external, angled projecting elements for use with flexible medical scoping devices such as endoscopesor enteroscopes. The invention includes the cover with an over cuff and use of the disposable removable covering in methods of medical scoping procedures or examinations. The invention also includes an applicator for assisting in placing the covering about or over a medical device and a kit of parts. | 2013-04-11 |